Ranbaxy Laboratories Ltd Merged Half Yearly Results

Gross Sales

5,590.24

5,609.14

5,334.12

5,073.02

5,339.32

Excise Duty

0

0

0

0

0

Net Sales

5,590.24

5,609.14

5,334.12

5,073.02

5,339.32

Other Operating Income

86.27

86.5

101.72

110.97

80.06

Other Income

52.56

164.89

61.47

97.8

142.73

Total Income

5,729.08

5,860.52

5,497.31

5,281.79

5,562.12

Total Expenditure

5,078.62

5,855.27

6,104.75

5,233.91

4,921.23

PBIDT

650.47

5.25

-607.44

47.88

640.89

Interest

279.63

232.02

270.6

211.66

120.08

PBDT

370.85

-226.77

-878.04

-163.77

520.81

Depreciation

0

224.91

0

155.94

162.11

Minority Interest Before NP

0

0

0

0

0

Tax

79.55

155.11

88.11

66.47

88.19

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

291.29

-606.8

-966.15

-386.17

270.51

Minority Interest After NP

-3.45

-1.64

2.75

5.3

6.33

Net Profit after Minority Interest

291.82

-613.1

-978.4

-398.48

261.72

Extra-ordinary Items

-179.1

-525.59

-771.9

-337.95

27.48

Adjusted Profit After Extra-ordinary item

470.92

-87.51

-206.5

-60.52

234.24

EPS (Unit Curr.)

6.88

0

-20.17

-9.42

6.19

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

211.94

211.55

211.52

211.55

211.46

Public Shareholding (Number)

14,93,13,904

14,80,01,952

14,28,03,328

14,56,79,328

14,52,39,372

Public Shareholding (%)

35.22

34.93

33.75

34.43

34.34

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

26,87,11,328

26,87,11,328

26,87,11,328

26,87,11,328

26,87,11,323

Non Encumbered - % in Total Promoters Holding

100

100

100

100

100

Non Encumbered - % in Total Equity

63.36

63.4

63.5

63.5

63.54

PBIDTM(%)

11.63

0.09

-11.38

0.94

12

PBDTM(%)

-

-

-

-

-

PATM(%)

5.21

-10.81

-18.11

-7.61

5.06